Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2023-03-29 00:00:00 ET · period of report 2023-03-27 · accession 0001415889-23-005600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-29 | 2023-03-27 | RANI | Groen Eric | GC | A - Grant | $0.00 | +139.0K | 163.2K | +574% | $0 |
| D | 2023-03-29 | 2023-03-27 | RANI | Groen Eric | GC | A - Grant | $0.00 | +205.8K | 205.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-27 | A | A | 139,000 | $0.00 | 163,216 | D | — | — | (F1) The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-27 | A | A | 205,800 | $0.00 | 205,800 | D | $5.44 · — to 2033-03-26 | 205,800 Class A Common Stock | (F2) The shares subject to the option vest as follows: 1/4th of the shares subject to the option vest monthly over four years from March 27, 2023. |